Birth-Control Drugmaker Evofem Biosciences Has Spiked 240

Di: Ava

PR Newswire SAN DIEGO , July 25, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has developed a new educational birth control chart that provides high-level information about the different options available to women in the United States . Evofem Biosciences has prescribed its nonhormonal contraceptive to more than 100,000 women but is still on the brink of collapse.

Stream The Future Of Birth Control, Sex, & Hormones With Evofem Biosciences CEO, Saundra Pelletier by The Skinny Confidential Him & Her Podcast on desktop and mobile. Play over 320 million tracks for free on SoundCloud. Evofem Biosciences | 在领英上有 9,447 位关注者。Developing and commercializing products that address unmet needs in women’s sexual and reproductive health. | Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and Phexxi® (lactic acid, citric acid, and potassium bitartrate) is an on-demand method of birth control used to prevent pregnancy. Phexxi is not effective when used after sex.

Evofem Biosciences on LinkedIn: #stis #chlamydia #gonorrhea

Birth-control drugmaker Evofem Biosciences has spiked 240% since the Supreme Court’s decision to overturn Roe vs. Wade Evofem Biosciences shares spiked 240% in the past two days following the overturning of Roe vs. Wade. The drugmaker owns Phexxi, one of the few non-hormonal birth control options available.

Evofem Biosciences, Inc. issued the following announcement on May 22. – A New Class of Female-Controlled Birth Control for Use In-The-Moment – – Robust Telemedicine Program Will Support Access for Women – – Company to Host Conference Call on Tuesday, May 26, 2020 at 8:30 a.m. ET – Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Phexxi, the first hormone-free gel contraceptive from Evofem Biosciences, is rewriting the rules of birth control with the help of Emmy-winning star of “Schitt’s Creek” Annie Murphy and her Watch Evofem Biosciences Soars as Birth-Control Gel Receives FDA OK – Breaking Hot News on Dailymotion

Image from https://hcp-phexxi.com About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel was found to be 86.3% effective with typical use when inserted up to 1 hour before vaginal Evofem Biosciences Inc. published this content on December 11, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on December 11, 2024 at 22:05:36.221.

Watch for safety info. Emily Pfender, PhD shares insights from her research on patients seeking non-hormonal birth control options due to concerns about hormonal side effects – and how Phexxi can

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, today reported additional data from its Phase 3 ‚AMPOWER‘ clinical trial of Amphora® for the prevention of pregnancy. These findings reveal that the use of Amphora, a first-in-class investigational Multipurpose Vaginal pH Claiming Control “My life was and has been very, very committed to doing what I can for equality,” says Saundra Pelletier, the founder and CEO of Evofem Biosciences, women’s sexual health focused biotech company. Last year, after a five-year FDA approval process, Evofem launched Phexxi, the first non-hormonal birth control gel for women.

Evofem Biosciences : 09.09.2024 EVFM Update Crystal Research

Evofem’s sole purpose is to improve the quality of lives of women worldwide by providing them with more control over their sexual and reproductive health. We Phexxi ® is an on-demand method of birth control used to prevent pregnancy. Phexxi is not effective when used after sex. Rare cases (0.36%) of bladder and kidney infection have been reported. If you have a history of urinary tract problems Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling. https://lnkd.in/dYrTreXi

San Diego biopharmaceutical company Evofem Biosciences is exploring a merger or acquisition to raise funds and get back on the national stock exchange.The commercial women’s health company an Find Evofem Biosciences’s most common email address formats to build your pipeline with confidence. Get accurate & updated contact data with LeadIQ. Book a demo today.

Evofem Biosciences Launches Phexxi: Will Peak Sales Surprise? (NASDAQ ...

Learn more about Evofem Biosciences’s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.

Evofem Biosciences, the buzzy but controversial women’s health startup that spent the past year trying to stay afloat, has finally found a buyer. About us Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that Evofem Biosciences Inc. published this content on March 24, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 24, 2025 at 12:53:08.583.

Evofem Biosciences. 9,134 likes · 10 were here. Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to

Saundra Pelletier has served as Chief Executive Officer, President and Executive Director of Evofem Biosciences(EVFM) since February 2015.

Evofem Biosciences Company Overview, Contact Details

An early July post on the TikTok account for Evofem Biosciences’ Phexxi birth control has sparked a surge in interest in the nonhormonal gel without even talking about the product—and In 2022, Evofem developed and introduced a new contraceptive educational chart for patients and healthcare providers, which details high-level information about birth control methods currently available to women in the U.S., including its vaginal pH modulator Phexxi.

San Diego biotech that makes non-hormonal birth control acquired for $100M After major cutbacks and financial challenges this year, Evofem Biosciences was acquired. Its lead product is a non

Learn how you can get a prescription for Phexxi® hormone free birth control through telehealth and have it delivered right to your door. About us Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health. In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that

Evofem Biosciences (EVFM) was rising sharply Tuesday after the Food and Drug Administration approved Phexxi, the company’s birth-control gel. The company expects to launch the product in early SAN DIEGO, July 15, 2025 /PRNewswire/ — One viral TikTok, 10 million+ views, and a flood of fearless, funny, and unfiltered replies later, a non-hormonal birth control brand — PHEXXI — has found itself at the center of a national conversation onmicrofeminism.

The biotech startup Evofem Biosciences is the maker of the contraceptive gel Phexxi, which was given FDA approval in 2020 as a non-hormonal, on-demand birth control option. News zur EVOFEM BIOSCIENCES AKTIE und aktueller Realtime-Aktienkurs Evofem Biosciences, Inc. – 8-K, Current Report

QQCWB

GV